Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11866411 Therapeutic compounds and compositions
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
March 8, 2021
0
Date of Patent
January 9, 2024
0
Patent Applicant
Agios Pharmaceuticals
0
Patent Application Number
17195243
0
Patent Citations
US Patent 7572913 4-substituted piperidine derivatives
0
US Patent 6979675 Treatment of cancer with 2-deoxyglucose
0
US Patent 7173025 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
0
US Patent 7288554 Ortho-substituted aryl amides for controlling invertebrate pests
0
US Patent 7524848 Diaza heterocyclic amide compounds and their uses
0
US Patent 7615553 Inhibitors of histone deacetylase
0
US Patent 7858782 Triazine derivatives and their therapeutical applications
0
US Patent 7863444 4-aminopyrrolopyrimidines as kinase inhibitors
0
US Patent 8058313 Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
0
US Patent 8133900 Use of bi-aryl meta-pyrimidine inhibitors of kinases
0
•••
Patent Inventor Names
Jeffrey O. Saunders
0
Shunqi Yan
0
Francesco G. Salituro
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11866411
0
Patent Primary Examiner
Brenda L Coleman
0
CPC Code
C07D 407/12
0
C07D 409/12
0
C07D 417/12
0
C07D 417/14
0
A61K 31/497
0
A61K 31/5513
0
A61K 31/4164
0
A61P 9/00
0
A61P 9/10
0
A61P 35/00
0
•••
Find more entities like US Patent 11866411 Therapeutic compounds and compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE